Akari Therapeutics Plc - ADR

NASDAQ:AKTX   3:59:41 PM EDT
1.87
+0.02 (+1.08%)
Products

Akari Therapeutics Receives FDA Fast Track Designation For Nomacopan To Treat Bullous Pemphigoid

Published: 04/28/2021 12:59 GMT
Akari Therapeutics Plc - ADR (AKTX) - Akari Therapeutics Receives FDA Fast Track Designation for Nomacopan for the Treatment of Bullous Pemphigoid.